Court Upholds Dismissal of Suit Against Maker of Endograft Device



DOCUMENTS
  • Order


SAN JOSE, Calif. - A California appellate court affirmed that claims brought against the manufacturer of an endograft device are preempted because the device received an investigational device exemption which is similar to the Food and Drug Administration's stringent premarket approval process. Robinson v. Endovascular Technologies Inc., No. H033951 (Calif. Ct. App., 6th Dist.).

On Nov. 19, the California 6th District Court of Appeal upheld dismissal of the suit against Endovascular Technologies Inc. Guidant Corp., Advanced Cardiovascular Systems Inc. and Origin Medsystems Inc.

In 1994, defendants submitted an application for an investigational device exemption to conduct clinical trials for …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS